glp 1 agonist dpp 4 inhibitor GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Role of Dipeptidyl Peptidase 4
Description
The researchers determined the impact of GLP-1RAs on weight fluctuations after bariatric surgery by analyzing the percentage of absolute differences in body weight (kg) or percentage of body changes

That openness is the pitch, and it undercuts Peak Wellnesss month-to-month rate

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Del Prato S., Kahn S

Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)

Lin L-Y, Warren-Gash C, Smeeth L, Chen P-C (2018) Data resource profile: the National Health Insurance Research Database (NHIRD)

Hua Medicine Ltd
